Editor’s note:For the latest news on COVID-19, visit http://bit.ly/AAPNewsCOVID19.

Federal health officials have verified 226 cases of myocarditis or pericarditis in people ages 30 and younger who have received an mRNA COVID-19 vaccine and are investigating about 250 more reports.

While rare, the rates for ages 16-24 following a second dose are above what is expected, prompting an emergency meeting of the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) next week.

“At that time, we’ll update the data, further evaluate myocarditis following mRNA vaccination and assess benefit/risk analysis,” said Tom Shimabukuro, M.D., M.P.H., M.B.A., deputy director of the Centers for Disease Control and Prevention’s (CDC’s) Immunization Safety Office.

Dr. Shimabukuro made a

Read More At Article Source | Article Attribution